HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

COMT Val(158) met genotype and striatal D(2/3) receptor binding in adults with 22q11 deletion syndrome.

Abstract
Although catechol-O-methyltransferase (COMT) activity evidently affects dopamine function in prefrontal cortex, the contribution is assumed less significant in striatum. We studied whether a functional polymorphism in the COMT gene (Val(158) Met) influences striatal D(2/3) R binding ratios (D(2/3) R BP(ND) ) in 15 adults with 22q11 deletion syndrome and hemizygous for this gene, using single photon emission computed tomography and the selective D(2/3) radioligand [(123) I]IBZM. Met hemizygotes had significantly lower mean D(2/3) R BPND than Val hemizygotes. These preliminary data suggest that low COMT activity may affect dopamine levels in striatum in humans and this may have implications for understanding the contribution of COMT activity to psychiatric disorders.
AuthorsErik Boot, Jan Booij, Janneke R Zinkstok, Frank Baas, Ann Swillen, Michael J Owen, Declan G Murphy, Kieran C Murphy, Don H Linszen, Thérèse A Van Amelsvoort
JournalSynapse (New York, N.Y.) (Synapse) Vol. 65 Issue 9 Pg. 967-70 (Sep 2011) ISSN: 1098-2396 [Electronic] United States
PMID21465565 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Wiley-Liss, Inc.
Chemical References
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Methionine
  • Catechol O-Methyltransferase
  • Valine
Topics
  • 22q11 Deletion Syndrome (diagnostic imaging, genetics, pathology)
  • Adolescent
  • Adult
  • Catechol O-Methyltransferase (genetics)
  • Corpus Striatum (diagnostic imaging, metabolism)
  • Female
  • Genotype
  • Humans
  • Male
  • Methionine (genetics)
  • Protein Binding (genetics)
  • Receptors, Dopamine D2 (metabolism)
  • Receptors, Dopamine D3 (metabolism)
  • Tomography, Emission-Computed, Single-Photon
  • Valine (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: